Why the study?
Does digoxin therapy have sex-based differences in mortality risk in patients with heart failure and depressed left ventricular systolic function?
Does digoxin therapy have sex-based differences in mortality risk in patients with heart failure and depressed left ventricular systolic function?
Digoxin therapy is associated with increased all-cause mortality in women with heart failure and reduced ejection fraction, highlighting a critical sex-based difference in safety.
May warrant avoiding digoxin in women with HFrEF; extends RCT evidence of sex-specific mortality risks.
The effect of digoxin therapy differs between men and women. Digoxin therapy is associated with an increased risk of death from any cause among women, but not men, with heart failure and depressed left ventricular systolic function.
No takes yet. Share an insight, caveat, or question.
Rathore et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: